Classifying variants in the CHEK2 gene: the importance of collaboration

被引：1
|
作者：
Espenschied, C. [1 ]
Kleiblova, P. [2 ,3 ,4 ]
Richardson, M. [1 ]
Stolarova, L. [5 ]
Soukupova, J. [5 ]
Zemankova, P. [5 ]
Vocka, M. [4 ,6 ]
Smith, L. Panos [7 ]
Dolinsky, J. [1 ]
Gau, C. L. [1 ]
Kleibl, Z. [5 ]
机构：
[1] Ambry Genet, Clin Diagnost, Aliso Viejo, CA USA
[2] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic
[3] First Fac Med, Inst Biol & Med Genet, Prague, Czech Republic
[4] Gen Univ Hosp Prague, Prague, Czech Republic
[5] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic
[6] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague, Czech Republic
[7] Ambry Genet, Genet, Aliso Viejo, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
10.1016/S0959-8049(17)30161-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Germline CHEK2 variants and risk of lymphoma
    Boddicker, Nicholas J.
    Mwangi, Raphael
    Robinson, Dennis P.
    Rosenthal, Allison C.
    Habermann, Thomas M.
    Feldman, Andrew L.
    Rimsza, Lisa M.
    King, Rebecca L.
    Larson, Melissa C.
    Gysbers, Brianna J.
    Ansell, Stephen M.
    Abeykoon, Jithma P.
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    Novak, Anne J.
    Slager, Susan L.
    Cerhan, James R.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
    Lawrenson, Kate
    Iversen, Edwin S.
    Tyrer, Jonathan
    Weber, Rachel Palmieri
    Concannon, Patrick
    Hazelett, Dennis J.
    Li, Qiyuan
    Marks, Jeffrey R.
    Berchuck, Andrew
    Lee, Janet M.
    Aben, Katja K. H.
    Anton-Culver, Hoda
    Antonenkova, Natalia
    Bandera, Elisa V.
    Bean, Yukie
    Beckmann, Matthias W.
    Bisogna, Maria
    Bjorge, Line
    Bogdanova, Natalia
    Brinton, Louise A.
    Brooks-Wilson, Angela
    Bruinsma, Fiona
    Butzow, Ralf
    Campbell, Ian G.
    Carty, Karen
    Chang-Claude, Jenny
    Chenevix-Trench, Georgia
    Chen, Ann
    Chen, Zhihua
    Cook, Linda S.
    Cramer, Daniel W.
    Cunningham, Julie M.
    Cybulski, Cezary
    Plisiecka-Halasa, Joanna
    Dennis, Joe
    Dicks, Ed
    Doherty, Jennifer A.
    Doerk, Thilo
    du Bois, Andreas
    Eccles, Diana
    Easton, Douglas T.
    Edwards, Robert P.
    Eilber, Ursula
    Ekici, Arif B.
    Fasching, Peter A.
    Fridley, Brooke L.
    Gao, Yu-Tang
    Gentry-Maharaj, Aleksandra
    Giles, Graham G.
    Glasspool, Rosalind
    CARCINOGENESIS, 2015, 36 (11) : 1341 - 1353
  • [3] CHEK2 Founder Variants and Thyroid Cancer Risk
    Brock, Pamela
    Liynarachchi, Sandya
    Nieminen, Taina T.
    Chan, Carlos
    Kohlmann, Wendy
    Stout, Leigh Anne
    Yao, Song
    La Greca, Amanda
    Jensen, Kirk E.
    Kolesar, Jill M.
    Salhia, Bodour
    Gulhati, Pat
    Hicks, J. Kevin
    Ringel, Matthew D.
    THYROID, 2024, 34 (04) : 477 - 483
  • [4] CHEK2 variants associate with hereditary prostate cancer
    E H Seppälä
    T Ikonen
    N Mononen
    V Autio
    A Rökman
    M P Matikainen
    T L J Tammela
    J Schleutker
    British Journal of Cancer, 2003, 89 : 1966 - 1970
  • [5] CHEK2 variants associate with hereditary prostate cancer
    Seppälä, EH
    Ikonen, T
    Mononen, N
    Autio, V
    Rökman, A
    Matikainen, MP
    Tammela, TLJ
    Schleutker, J
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1966 - 1970
  • [6] CHEK2 Pathogenic Germline Variants in Patients With NSCLC
    Sorscher, Steven
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (12):
  • [7] Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2
    Bychkovsky, Brittany L.
    Agaoglu, Nihat B.
    Horton, Carolyn
    Zhou, Jing
    Yussuf, Amal
    Hemyari, Parichehr
    Richardson, Marcy E.
    Young, Colin
    LaDuca, Holly
    McGuinness, Deborah L.
    Scheib, Rochelle
    Garber, Judy E.
    Rana, Huma Q.
    JAMA ONCOLOGY, 2022, 8 (11) : 1598 - 1606
  • [8] Beyond CHEK2 in breast cancer: Search for additional moderately penetrant risk gene variants by analyzing the oligogenic disease course in CHEK2 mutation carriers
    Pohl, E.
    Borde, J.
    Hauke, J.
    Schmidt, S.
    Weber-Lassalle, K.
    Ernst, C.
    Niederacher, D.
    Arnold, N.
    Hellebrand, H.
    Meindl, A.
    Gehrig, A.
    Schmidt, G.
    Dutrannoy, V.
    Kast, K.
    Hahnen, E.
    Schmutzler, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 535 - 536
  • [9] CHEK2 gene somatic loss in breast tumors from carriers of germline CHEK2 mutations
    Iyevleva, A.
    Aleksakhina, S.
    Sokolenko, A.
    Baskina, S.
    Venina, A.
    Anisimova, E.
    Bizin, I. V.
    Ivantsov, A. O.
    Imyanitov, E. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S1232 - S1232
  • [10] Beyond CHEK2 in breast cancer: Search for additional moderately penetrant risk gene variants by analyzing the oligogenic disease course in CHEK2 mutation carriers
    Pohl, E.
    Richters, L.
    Hauke, J.
    Ernst, C.
    Krober, S.
    Niederacher, D.
    Arnold, N.
    Ramser, J.
    Gross, E.
    Gehrig, A.
    Schmidt, G.
    Dutrannoy, V.
    Kast, K.
    Hahnen, E.
    Schmutzler, R.
    CANCER RESEARCH, 2017, 77
12345